ARCH Venture Partners, Flagship Ventures and MD Anderson collaborate to launch Codiak BioSciences

Codiak BioSciences, Inc. announced today the closing of the first portion of a planned $80-plus million Series A and B financing.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news